Insider · CIK 0001707685

Utter Christine Marie

Reports to the SEC for 1 company · WARREN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001707685

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+19.7K sh	$25.69	+$506K	89,885
2026-06-17	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−19.7K sh	$75.56	−$1.49M	70,199
2026-06-17	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−19.7K sh	—	—	15,314
2026-02-18	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−2,494 sh	$69.36	−$173K	70,199
2026-01-08	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−1,034 sh	$76.45	−$79K	72,693
2026-01-07	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−1,235 sh	$77.45	−$95.7K	73,727
2026-01-06	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−1,381 sh	$76.95	−$106K	74,962
2026-01-02	PTCTPTC THERAPEUTICS, INC.A Award	SVP, CHIEF ACCOUNTING OFFICER	AAward	+13.3K sh	—	—	76,343
2026-01-02	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	SVP, CHIEF ACCOUNTING OFFICER	AAward	+33.1K sh	—	—	33,125
2025-02-20	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−878 sh	$50.12	−$44K	62,564
2025-02-19	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−879 sh	$50.10	−$44K	63,442
2025-01-08	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−1,662 sh	$44.50	−$74K	64,321
2025-01-07	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−1,291 sh	$45.34	−$58.5K	65,983
2025-01-03	PTCTPTC THERAPEUTICS, INC.A Award	SVP, CHIEF ACCOUNTING OFFICER	AAward	+14K sh	—	—	67,274
2025-01-03	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	SVP, CHIEF ACCOUNTING OFFICER	AAward	+35K sh	—	—	35,000
2024-12-02	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+3,105 sh	$51.00	+$158K	55,533
2024-12-02	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−2,497 sh	$51.34	−$128K	53,036
2024-12-02	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−608 sh	$52.24	−$31.8K	52,428
2024-12-02	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+14.7K sh	$51.00	+$749K	67,123
2024-12-02	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−9,919 sh	$51.53	−$511K	57,204
2024-12-02	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−4,776 sh	$52.45	−$251K	52,428
2024-12-02	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−3,105 sh	—	—	14,695
2024-12-02	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−14.7K sh	—	—	0
2024-02-15	PTCTPTC THERAPEUTICS, INC.A Award	SVP, CHIEF ACCOUNTING OFFICER	AAward	+14K sh	—	—	49,528
2024-02-15	PTCTPTC THERAPEUTICS, INC.A Award	SVP, CHIEF ACCOUNTING OFFICER	AAward	+2,900 sh	—	—	52,428
2024-02-15	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	SVP, CHIEF ACCOUNTING OFFICER	AAward	+35K sh	—	—	35,000
2024-01-30	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−318 sh	$27.25	−$8,665.754	35,528
2024-01-09	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−1,653 sh	$29.01	−$48K	35,846
2024-01-08	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−1,188 sh	$28.64	−$34K	37,499
2023-04-21	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+4,321 sh	$33.02	+$143K	42,380
2023-04-21	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−4,321 sh	$55.05	−$238K	38,059
2023-04-21	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+371 sh	$33.02	+$12.3K	38,430
2023-04-21	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−351 sh	$55.09	−$19.3K	38,079
2023-04-21	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−20 sh	$55.64	−$1,112.8	38,059
2023-04-21	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−4,321 sh	$33.02	−$143K	0
2023-04-21	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−371 sh	$33.02	−$12.3K	0
2023-03-29	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+4,688 sh	$40.45	+$190K	42,747
2023-03-29	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−3,247 sh	$47.80	−$155K	39,500
2023-03-29	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−1,441 sh	$47.78	−$68.8K	38,059
2023-03-29	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−4,688 sh	$40.45	−$190K	0
2023-03-27	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+16.9K sh	$33.02	+$559K	54,988
2023-03-27	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−7,949 sh	$44.72	−$355K	47,039
2023-03-27	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−8,780 sh	$45.42	−$399K	38,259
2023-03-27	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−200 sh	$46.01	−$9,201	38,059
2023-03-27	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	+9,729 sh	$33.02	+$321K	47,788
2023-03-27	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−4,475 sh	$44.71	−$200K	43,313
2023-03-27	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−4,954 sh	$45.38	−$225K	38,359
2023-03-27	PTCTPTC THERAPEUTICS, INC.S Sale	SVP, CHIEF ACCOUNTING OFFICER	SSale	−300 sh	$46.01	−$13.8K	38,059
2023-03-27	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−16.9K sh	$33.02	−$559K	4,321
2023-03-27	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP, CHIEF ACCOUNTING OFFICER	MExercise/Conversion	−9,729 sh	$33.02	−$321K	371

Recent filings

Accepted (ET)
Jun 224
Utter Christine Marie0001707685-26-000010
SEC(opens sec.gov)
Feb 204
Utter Christine Marie0001707685-26-000008
SEC(opens sec.gov)
Jan 124
Utter Christine Marie0001707685-26-000006
SEC(opens sec.gov)
Jan 84
Utter Christine Marie0001707685-26-000004
SEC(opens sec.gov)
Jan 64
Utter Christine Marie0001707685-26-000002
SEC(opens sec.gov)
Feb 214
Utter Christine Marie0001415889-25-005139
SEC(opens sec.gov)
Jan 104
Utter Christine Marie0001415889-25-001295
SEC(opens sec.gov)
Jan 74
Utter Christine Marie0001415889-25-001021
SEC(opens sec.gov)
Dec 44
Utter Christine Marie0001415889-24-028286
SEC(opens sec.gov)

Companies

PTC THERAPEUTICS, INC.SVP, CHIEF ACCOUNTING OFFICERPTCT

Address

C/O PTC THERAPEUTICS, INC. 500 WARREN CORPORATE CENTER DRIVE

WARREN, NJ, 07059